Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2-3
|
pubmed:dateCreated |
1993-11-9
|
pubmed:abstractText |
The present study investigated the effects of a alpha 2-adrenoceptor agonist, D-medetomidine (0.3, 3.0, 30.0 and 300.0 micrograms/kg, s.c.), on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats. D-Medetomidine at 0.3, 3.0, and 30.0 micrograms/kg dose dependently increased waking-immobility-related high-voltage spike and wave spindles. Movement and waking-immobility-related slow wave activity was increased at doses of 3.0, 30.0 and 300.0 micrograms/kg. D-Medetomidine at 300.0 micrograms/kg produced continuous 1-2 Hz slow wave activity and the animals were markedly sedated. In rats injected with D-medetomidine at 0.3, 3.0 and 30.0, micrograms/kg EEG activity could be desynchronized (block of high-voltage spindles and slow waves) by pinching the tail. However, rats injected with D-medetomidine at 300.0 micrograms/kg showed no change in EEG activity or behavior following tail pinching. D-Medetomidine induced similar EEG activity (high-voltage spindles and slow waves) and behavioral changes (sedation) in 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats. Atipamezole, an alpha 2-adrenoceptor antagonist, blocked D-medetomidine-induced EEG and behavioral changes in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats. Based on the present results we suggest that stimulation of presynaptic noradrenergic fibers is not a prerequisite for the increase of high-voltage spindle and slow wave activity induced by an alpha 2-adrenoceptor agonist and that the magnitude of EEG slowing induced by D-medetomidine correlates with the decreased behavioral response to sensory stimulation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Medetomidine,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidopamine,
http://linkedlifedata.com/resource/pubmed/chemical/atipamezole
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
238
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
263-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8104809-Adrenergic Fibers,
pubmed-meshheading:8104809-Adrenergic alpha-Agonists,
pubmed-meshheading:8104809-Adrenergic alpha-Antagonists,
pubmed-meshheading:8104809-Animals,
pubmed-meshheading:8104809-Behavior, Animal,
pubmed-meshheading:8104809-Dose-Response Relationship, Drug,
pubmed-meshheading:8104809-Electroencephalography,
pubmed-meshheading:8104809-Imidazoles,
pubmed-meshheading:8104809-Injections, Subcutaneous,
pubmed-meshheading:8104809-Locus Coeruleus,
pubmed-meshheading:8104809-Male,
pubmed-meshheading:8104809-Medetomidine,
pubmed-meshheading:8104809-Oxidopamine,
pubmed-meshheading:8104809-Rats,
pubmed-meshheading:8104809-Rats, Wistar
|
pubmed:year |
1993
|
pubmed:articleTitle |
The effects of alpha 2-adrenoceptor stimulation on neocortical EEG activity in control and 6-hydroxydopamine dorsal noradrenergic bundle-lesioned rats.
|
pubmed:affiliation |
University of Kuopio, Department of Neurology, A.I. Virtanen Institute, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|